GKIM
CLX icon

GW&K Investment Management’s Clorox CLX Stock Holding History

GW&K Investment Management’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Sell
115
-51
-31% -$4.9K ﹤0.01% 888
2026
Q1 		$17K Buy
166
+63
+61% +$7.14K ﹤0.01% 804
2025
Q4 		$10K Sell
103
-33
-24% -$3.58K ﹤0.01% 858
2025
Q3 		$17K Buy
136
+52
+62% +$6.45K ﹤0.01% 775
2025
Q2 		$10K Sell
84
-211
-72% -$28.2K ﹤0.01% 840
2025
Q1 		$43K Buy
295
+208
+239% +$31.8K ﹤0.01% 512
2024
Q4 		$14K Buy
87
+12
+16% +$1.96K ﹤0.01% 686
2024
Q3 		$12K Buy
75
+7
+10% +$1.04K ﹤0.01% 727
2024
Q2 		$9K Buy
68
+8
+13% +$1.11K ﹤0.01% 748
2024
Q1 		$9K Sell
60
-1
-2% -$149 ﹤0.01% 721
2023
Q4 		$9K Buy
61
+9
+17% +$1.2K ﹤0.01% 695
2023
Q3 		$7K Sell
52
-2
-4% -$304 ﹤0.01% 697
2023
Q2 		$9K Buy
+54
New +$8.71K ﹤0.01% 628
2022
Q3 		– Sell
-46
Closed -$6K – 481
2022
Q2 		$6K Buy
46
+25
+119% +$3.57K ﹤0.01% 546
2022
Q1 		$3K Buy
+21
New +$3.22K ﹤0.01% 628

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

GW&K Investment Management's CLX Position: Q2 2026 in Review

GW&K Investment Management reduced its Clorox (CLX) stake by 31% in Q2 2026, selling an estimated $4.9K and leaving 115 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #888.

GW&K Investment Management first reported a position in CLX in Q1 2022 and has held it in 15 quarters since. The position peaked at $43K in Q1 2025. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • GW&K Investment Management held 115 shares of Clorox worth $11K as of Q2 2026.
  • GW&K Investment Management sold 51 Clorox shares in Q2 2026, an estimated $4.9K.
  • Clorox made up ﹤0.01% of GW&K Investment Management's portfolio in Q2 2026, its #888 holding.
  • GW&K Investment Management first reported a position in Clorox in Q1 2022 and has held it in 15 quarters since.
  • GW&K Investment Management's Clorox position peaked at $43K in Q1 2025.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.